A quick and brief description on the differences of tizepatide and semaglutide.
Both tirzepatide and semaglutide have shown significant weight loss benefits in clinical trials, but there are some differences in their efficacy and dosing for weight loss. Here’s an explanation of the differences between tirzepatide and semaglutide regarding weight loss:
Clinical Trials and Efficacy:
Tirzepatide: Tirzepatide has demonstrated notable weight loss effects in clinical trials. In a phase 3 trial called SURPASS-1, tirzepatide showed superior weight loss results compared to semaglutide. Participants taking tirzepatide experienced an average weight loss of around 12.4% of their body weight, while those on semaglutide had an average weight loss of around 6.2%.
Semaglutide: Semaglutide has also demonstrated significant weight loss effects. In a large-scale clinical trial known as STEP (Semaglutide Treatment Effect in People with obesity), semaglutide showed an average weight loss of around 15% of body weight over a 68-week period.
It’s important to note that weight loss medications should be prescribed and used under the supervision of a healthcare professional, and individual responses to these medications may vary. It’s always advisable to consult up-to-date medical information or healthcare professionals for the latest information on these medications.
Feel Free to contact Active Medical Group if you have any question https://activemedicalgroup.com/
